Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure Limited (NASDAQ:NVCR – Free Report) – Wedbush upped their Q1 2024 earnings estimates for NovoCure in a research report issued to clients and investors on Thursday, February 22nd. Wedbush analyst D. Nierengarten now expects that the medical equipment provider will post earnings of ($0.36) per share for the quarter, up from their prior estimate […]
NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities research analysts at Wedbush increased their Q1 2024 earnings per share (EPS) estimates for shares of NovoCure in a research note issued to investors on Thursday, February 22nd. Wedbush analyst D. Nierengarten now anticipates that the medical equipment provider will post earnings per share of ($0.36) for […]
NovoCure (NASDAQ:NVCR – Free Report) had its price target hoisted by Evercore ISI from $14.00 to $15.00 in a research report report published on Friday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the medical equipment provider’s stock. A number of other equities research analysts also recently weighed in on the company. […]
NovoCure Limited (NASDAQ:NVCR – Free Report) – Stock analysts at HC Wainwright issued their FY2028 earnings estimates for NovoCure in a note issued to investors on Thursday, February 22nd. HC Wainwright analyst E. Bodnar expects that the medical equipment provider will post earnings of ($1.01) per share for the year. HC Wainwright has a “Buy” […]
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have assigned a buy recommendation to the […]